Mark B. Geyer
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Hematology top 5%
- Genetics top 10%
- Co-authors
- Renier J. BrentjensJae H. ParkJohn ManisCristian BoboilăAli A. ZarrinCatherine T. YanFrederick W. AltMichael Murphy
- Topics
- Acute Lymphoblastic Leukemia research (23 papers)CAR-T cell therapy research (18 papers)Acute Myeloid Leukemia Research (14 papers)
- Cited by
- OncologyHematologyGenetics
- Partner nations
- United StatesUnited KingdomThailand
In The Last Decade
Mark B. Geyer
55 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 75
- Oncology 814
- Molecular Biology 613
- Immunology 353
- Hematology 279
- Genetics 229
Countries citing papers authored by Mark B. Geyer
This map shows the geographic impact of Mark B. Geyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Geyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Geyer more than expected).
Fields of papers citing papers by Mark B. Geyer
This network shows the impact of papers produced by Mark B. Geyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Geyer. The network helps show where Mark B. Geyer may publish in the future.
Co-authorship network of co-authors of Mark B. Geyer
This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Geyer. A scholar is included among the top collaborators of Mark B. Geyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Geyer. Mark B. Geyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 29 | |
| 7 | 67 | |
| 8 | 69 | |
| 9 | 42 | |
| 10 | 0 | |
| 11 | 60 | |
| 12 | 4 | |
| 13 | 289 | |
| 14 | 25 | |
| 15 | 2 | |
| 16 | 25 | |
| 17 | 37 | |
| 18 | 22 | |
| 19 | 47 | |
| 20 | 450 |
About Mark B. Geyer
Mark B. Geyer is a scholar working on Hematology, Genetics and Oncology, having authored 61 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (23 papers), CAR-T cell therapy research (18 papers) and Acute Myeloid Leukemia Research (14 papers). The work is most often cited by research in Oncology (814 citations), Hematology (279 citations) and Genetics (210 citations). Mark B. Geyer has collaborated with scholars based in United States, United Kingdom and Thailand. Frequent co-authors include Renier J. Brentjens, Jae H. Park, John Manis, Cristian Boboilă, Ali A. Zarrin, Catherine T. Yan, Frederick W. Alt, Michael Murphy, Thomas R. Hickernell and Klaus Rajewsky. Their work appears in journals such as Nature, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.